pISSN 1226-6051
eISSN 2508-786X

Table. 8.

Table. 8.

Duration of voriconazole use between therapeutic drug monitoring (TDM) and non-TDM groups

TotalTreatment success group
TDM (n = 27)non-TDM (n = 27)p-valueTDM (n = 13)non-TDM (n = 11)p-value
Duration of voriconazole use, days164 [32-937]69 [10-571]0.004170.9 ± 67.3137.1 ± 97.40.327

Data are the mean ± SD or median [min-max] From the Independent t-test or Mann-Whitney U test

Korean J Clin Pharm 2019;29:89-100 https://doi.org/10.24304/kjcp.2019.29.2.89
© 2019 Korean J Clin Pharm